Company / Tangible Book Value per Share
Lineage Cell Therapeutics, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.15
FY2025
5-year range
$0.15 / $0.53
FY2021-FY2025
Trend
-60.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $0.15 in FY2025 to $1.58 in FY2017.
Based on SEC 10-K filings.
0.15 in FY2025 with a 5-year CAGR of -23.1%.
Declined from $0.31 to $0.15 over the past 2 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -25.4%
- 5-Year CAGR
- -23.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 60.3% year-over-year.
- Peak tangible book value per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.15 | -60.3% |
| FY2024 | $0.39 | +24.8% |
| FY2023 | $0.31 | -16.1% |
| FY2022 | $0.37 | -30.6% |
| FY2021 | $0.53 | -6.7% |
| FY2020 | $0.57 | -12.7% |
| FY2019 | $0.65 | -11.6% |
| FY2018 | $0.74 | -53.3% |
| FY2017 | $1.58 | +21.3% |
| FY2016 | $1.30 | +279.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026